Nuveen Asset Management, LLC Sqz Biotechnologies CO Transaction History

Nuveen Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.77 - $5.0 $215,378 - $388,770	-77,754 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.01 - $10.42 $5,401 - $14,035	1,347 Added 1.76%	77,754 $370,000
Q4 2021 Feb 14, 2022	SELL	$8.93 - $14.85 $53,963 - $89,738	-6,043 Reduced 7.33%	76,407 $762,000
Q3 2021 Nov 12, 2021	SELL	$11.46 - $15.77 $31,274 - $43,036	-2,729 Reduced 3.2%	82,450 $1.19 Million
Q2 2021 Aug 16, 2021	BUY	$11.32 - $14.45 $964,226 - $1.23 Million	85,179 New	85,179 $1.23 Million
Q1 2021 May 17, 2021	SELL	$12.07 - $29.9 $88,207 - $218,509	-7,308 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$13.25 - $34.58 $96,831 - $252,710	7,308 New	7,308 $212,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.